L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Coburn, Lori A ^a,c   Gong, Xue ^a   Singh, Kshipra ^a,c   Asim, Mohammad ^a,c   Scull, Brooks P ^a   Allaman, Margaret M ^a   Williams, Christopher S ^a,c   Rosen, Michael J ^a   Washington, M Kay ^b   Barry, Daniel P ^a,c   Piazuelo, M Blanca ^a   Casero, Robert A ^d   Chaturvedi, Rupesh ^a,c   Zhao, Zhongming ^a   Wilson, Keith T ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; ARGININE; DEXTRAN SULFATE; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; KERATINOCYTE DERIVED CHEMOKINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1BETA; MYELOPEROXIDASE; NITRIC OXIDE; ORNITHINE DECARBOXYLASE; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AMINO ACID; CHEMOKINE; CYTOKINE; NOS2 PROTEIN, MOUSE; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; COLITIS; COLON INJURY; COLON MUCOSA; COLON WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG UPTAKE; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENOME ANALYSIS; INTESTINE MUCOSA PERMEABILITY; MALE; MICROARRAY ANALYSIS; MOUSE; NEUTROPHIL COUNT; NONHUMAN; ORGAN WEIGHT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; SUPPLEMENTATION; SURVIVAL RATE; UPREGULATION; WEIGHT REDUCTION; WOUND HEALING; ANIMAL; BLOOD; C57BL MOUSE; CELL MOTION; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; DRUG EFFECT; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; NEUTROPHIL; ORGAN SIZE; PATHOLOGY; PERMEABILITY; PHYSIOLOGY; ULCERATIVE COLITIS; WESTERN BLOTTING;

MURINAE; MUS;

AMINO ACIDS; ANIMALS; ARGININE; BLOTTING, WESTERN; CATIONIC AMINO ACID TRANSPORTER 2; CELL MOVEMENT; CHEMOKINES; COLITIS, ULCERATIVE; CYTOKINES; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; DNA PRIMERS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SIZE; PERMEABILITY; WEIGHT LOSS;

EID: 84858040869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033546     Document Type: Article

References (67)

1. Baumgart DC, Carding SR, (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640.
2. Baumgart DC, Sandborn WJ, (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657.
3. Rose WC, (1949) Amino acid requirements of man. Fed Proc 8: 546-552.
4. Castillo L, Ajami A, Branch S, Chapman TE, Yu YM, et al. (1994) Plasma arginine kinetics in adult man: response to an arginine-free diet. Metabolism 43: 114-122.
5. Castillo L, Chapman TE, Sanchez M, Yu YM, Burke JF, et al. (1993) Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets. Proc Natl Acad Sci U S A 90: 7749-7753.
6. Kakuda DK, Sweet MJ, Mac Leod CL, Hume DA, Markovich D, (1999) CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages. Biochem J 340 (Pt 2): 549-553.
7. Martin L, Comalada M, Marti L, Closs EI, MacLeod CL, et al. (2006) Granulocyte-macrophage colony-stimulating factor increases L-arginine transport through the induction of CAT2 in bone marrow-derived macrophages. Am J Physiol Cell Physiol 290: C1364-1372.
8. Nicholson B, Manner CK, Kleeman J, MacLeod CL, (2001) Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J Biol Chem 276: 15881-15885.
9. Closs EI, Simon A, Vekony N, Rotmann A, (2004) Plasma membrane transporters for arginine. J Nutr 134: 2752S-2759S; discussion 2765S-2767S.
10. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, et al. (2004) CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch 447: 532-542.
11. Closs EI, Basha FZ, Habermeier A, Forstermann U, (1997) Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1: 65-73.
12. Coman D, Yaplito-Lee J, Boneh A, (2008) New indications and controversies in arginine therapy. Clin Nutr 27: 489-496.
13. Mori M, (2007) Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J Nutr 137: 1616S-1620S.
14. Lewis ND, Asim M, Barry DP, Singh K, de Sablet T, et al. (2010) Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J Immunol 184: 2572-2582.
15. Wu G, Morris SM Jr, (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336 (Pt 1): 1-17.
16. Li L, Rao JN, Guo X, Liu L, Santora R, et al. (2001) Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation. Am J Physiol Cell Physiol 281: C941-953.
17. Rao JN, Li L, Golovina VA, Platoshyn O, Strauch ED, et al. (2001) Ca2+-RhoA signaling pathway required for polyamine-dependent intestinal epithelial cell migration. Am J Physiol Cell Physiol 280: C993-1007.
18. Rhoads JM, Chen W, Gookin J, Wu GY, Fu Q, et al. (2004) Arginine stimulates intestinal cell migration through a focal adhesion kinase dependent mechanism. Gut 53: 514-522.
19. Li H, Meininger CJ, Kelly KA, Hawker JR Jr, Morris SM Jr, et al. (2002) Activities of arginase I and II are limiting for endothelial cell proliferation. Am J Physiol Regul Integr Comp Physiol 282: R64-69.
20. Pegg AE, McCann PP, (1982) Polyamine metabolism and function. Am J Physiol 243: C212-221.
21. Albina JE, Abate JA, Mastrofrancesco B, (1993) Role of ornithine as a proline precursor in healing wounds. J Surg Res 55: 97-102.
22. Yoo JS, Sakamoto T, Spee C, Kimura H, Harris MS, et al. (1997) cis-Hydroxyproline inhibits proliferation, collagen synthesis, attachment, and migration of cultured bovine retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 38: 520-528.
23. Cross RK, Wilson KT, (2003) Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 9: 179-189.
24. Fotiadis C, Adamis S, Misiakos EP, Genetzakis M, Antonakis PT, et al. (2007) The prophylactic effect of L-arginine in acute ischaemic colitis in a rat model of ischaemia/reperfusion injury. Acta Chir Belg 107: 192-200.
25. Gobert AP, Cheng Y, Akhtar M, Mersey BD, Blumberg DR, et al. (2004) Protective role of arginase in a mouse model of colitis. J Immunol 173: 2109-2117.
26. Morris SM Jr, (2004) Enzymes of arginine metabolism. J Nutr 134: 2743S-2747S; discussion 2765S-2767S.
27. Hong SK, Maltz BE, Coburn LA, Slaughter JC, Chaturvedi R, et al. (2010) Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity. Inflamm Bowel Dis 16: 105-111.
28. Loftus CG, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, et al. (2007) Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 13: 254-261.
29. Kojouharoff G, Hans W, Obermeier F, Mannel DN, Andus T, et al. (1997) Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107: 353-358.
30. Murthy S, Cooper HS, Yoshitake H, Meyer C, Meyer CJ, et al. (1999) Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. Aliment Pharmacol Ther 13: 251-260.
31. Present DH, (1999) Review article: the efficacy of infliximab in Crohn's disease-healing of fistulae. Aliment Pharmacol Ther 13 (Suppl 4): 23-28; discussion 38.
32. Mouser JF, Hyams JS, (1999) Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn's disease. Clin Ther 21: 932-942; discussion 931.
33. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, et al. (1999) Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340: 1398-1405.
34. Clark M, Colombel JF, Feagan BC, Fedorak RN, Hanauer SB, et al. (2007) American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology 133: 312-339.
35. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, et al. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702.
36. Singh K, Chaturvedi R, Barry DP, Coburn LA, Asim M, et al. (2011) The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis. J Biol Chem 286: 3839-3850.
37. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, et al. (2001) Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 194: 1207-1218.
38. Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, et al. (2002) Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. J Clin Invest 110: 1773-1782.
39. Theiss AL, Vijay-Kumar M, Obertone TS, Jones DP, Hansen JM, et al. (2009) Prohibitin is a novel regulator of antioxidant response that attenuates colonic inflammation in mice. Gastroenterology 137: 199-208, 208 e191-196.
40. Sartor RB, (2006) Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3: 390-407.
41. Williams KL, Fuller CR, Dieleman LA, DaCosta CM, Haldeman KM, et al. (2001) Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 120: 925-937.
42. Singh K, Chaturvedi R, Asim M, Barry DP, Lewis ND, et al. (2008) The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappa B activation. J Biol Chem 283: 16752-16761.
43. Chaturvedi R, Asim M, Hoge S, Lewis ND, Singh K, et al. (2010) Polyamines impair immunity to Helicobacter pylori by inhibiting L-arginine uptake required for nitric oxide production. Gastroenterology 139: 1686-1698, 1698 e1681-1686.
44. Chaturvedi R, Asim M, Lewis ND, Algood HM, Cover TL, et al. (2007) L-Arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun 75: 4305-4315.
45. Chaturvedi R, Cheng Y, Asim M, Bussiere FI, Xu H, et al. (2004) Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J Biol Chem 279: 40161-40173.
46. Cheng Y, Chaturvedi R, Asim M, Bussiere FI, Xu H, et al. (2005) Helicobacter pylori-induced macrophage apoptosis requires activation of ornithine decarboxylase by c-Myc. J Biol Chem 280: 22492-22496.
47. Bussiere FI, Chaturvedi R, Cheng Y, Gobert AP, Asim M, et al. (2005) Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem 280: 2409-2412.
48. Barry DP, Asim M, Scull BP, Piazuelo MB, de Sablet T, et al. (2011) Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection. PLoS One 6: e29046.
49. Chaturvedi AK, Kemp TJ, Pfeiffer RM, Biancotto A, Williams M, et al. (2011) Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. Cancer Epidemiol Biomarkers Prev 20: 1902-1911.
50. Sun Y, Zheng S, Torossian A, Speirs CK, Schleicher S, et al. (2011) Role of Insulin-Like Growth Factor-1 Signaling Pathway in Cisplatin-Resistant Lung Cancer Cells. Int J Radiat Oncol Biol Phys.
51. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
52. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
53. Gerner EW, (2007) Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models. Biochem Soc Trans 35: 322-325.
54. Adibi SA, Gray SJ, Menden E, (1967) The kinetics of amino acid absorption and alteration of plasma composition of free amino acids after intestinal perfusion of amino acid mixtures. Am J Clin Nutr 20: 24-33.
55. Nixon SE, Mawer GE, (1970) The digestion and absorption of protein in man. 2. The form in which digested protein is absorbed. Br J Nutr 24: 241-258.
56. Domek MJ, Iwata F, Blackman EI, Kao J, Baker M, et al. (1995) Anti-neutrophil serum attenuates dextran sulfate sodium-induced colonic damage in the rat. Scand J Gastroenterol 30: 1089-1094.
57. Weaver CT, Murphy KM, (2007) The central role of the Th17 lineage in regulating the inflammatory/autoimmune axis. Semin Immunol 19: 351-352.
58. Packey CD, Sartor RB, (2008) Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 263: 597-606.
59. Wang JY, Viar MJ, Li J, Shi HJ, McCormack SA, et al. (1997) Polyamines are necessary for normal expression of the transforming growth factor-beta gene during cell migration. Am J Physiol 272: G713-720.
60. Mashimo H, Goyal RK, (1999) Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol 277: G745-750.
61. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, et al. (2001) Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 194: 1207-1218.
62. Gookin JL, Rhoads JM, Argenzio RA, (2002) Inducible nitric oxide synthase mediates early epithelial repair of porcine ileum. Am J Physiol Gastrointest Liver Physiol 283: G157-168.
63. Kavalukas SL, Uzgare AR, Bivalacqua TJ, Barbul A, (2011) Arginase inhibition promotes wound healing in mice. Surgery.
64. Bove PF, Wesley UV, Greul AK, Hristova M, Dostmann WR, et al. (2007) Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am J Respir Cell Mol Biol 36: 138-146.
65. Tripathi P, Singh TP, Chandra M, Misra MK, (2010) L-arginine is effective in scavenging oxygen derived free radicals in the patients of ischemic heart diseases. Int J Biol Med Res 1: 15-19.
66. Binion DG, Fu S, Ramanujam KS, Chai YC, Dweik RA, et al. (1998) iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol 275: G592-603.
67. Binion DG, Rafiee P, Ramanujam KS, Fu S, Fisher PJ, et al. (2000) Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic Biol Med 29: 881-888.